Phase I trial of R 118 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 13 Aug 2014
At a glance
- Drugs R 118 (Primary)
- Indications Intermittent claudication
- Focus Adverse reactions
- Sponsors Rigel Pharmaceuticals
- 13 Aug 2014 Results published in Rigel Pharmaceuticals media release.
- 13 Aug 2014 Rigel Pharmaceuticals has discontinued the R 118 programme due to the side-effect profile in phase I trials, according to a media release.
- 13 Aug 2014 Status changed from recruiting to discontinued, according to a Rigel Pharmaceuticals media release.